121 related articles for article (PubMed ID: 38396829)
1. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
van Agthoven T; Eijkenboom WMH; Looijenga LHJ
Cell Oncol (Dordr); 2017 Aug; 40(4):379-388. PubMed ID: 28612337
[TBL] [Abstract][Full Text] [Related]
2. Combining Hypermethylated
Lobo J; van Zogchel LMJ; Nuru MG; Gillis AJM; van der Schoot CE; Tytgat GAM; Looijenga LHJ
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680375
[TBL] [Abstract][Full Text] [Related]
3. Testicular germ cell tumor: a comprehensive review.
Batool A; Karimi N; Wu XN; Chen SR; Liu YX
Cell Mol Life Sci; 2019 May; 76(9):1713-1727. PubMed ID: 30671589
[TBL] [Abstract][Full Text] [Related]
4. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
[TBL] [Abstract][Full Text] [Related]
5. Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.
Belge G; Dumlupinar C; Nestler T; Klemke M; Törzsök P; Trenti E; Pichler R; Loidl W; Che Y; Hiester A; Matthies C; Pichler M; Paffenholz P; Kluth L; Wenzel M; Sommer J; Heinzelbecker J; Schriefer P; Winter A; Zengerling F; Kramer MW; Lengert M; Frey J; Heidenreich A; Wülfing C; Radtke A; Dieckmann KP
Clin Cancer Res; 2024 Jan; 30(2):404-412. PubMed ID: 37967143
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures.
Santarosa Vieira AG; da Silva LS; Albino da Silva EC; Laus AC; Faria TMV; van Helvoort Lengert A; Martins GE; de Oliveira MA; Reis RM; Lopes LF; Pinto MT
Mol Oncol; 2024 May; ():. PubMed ID: 38725152
[TBL] [Abstract][Full Text] [Related]
7. Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell Tumours.
Dieckmann KP; Grobelny F; Soave A; Che Y; Nestler T; Matthies C; Heinzelbecker J; Winter A; Heidenreich A; Niemzok T; Dumlupinar C; Angerer M; Wülfing C; Paffenholz P; Belge G
Eur Urol Focus; 2024 May; ():. PubMed ID: 38729824
[TBL] [Abstract][Full Text] [Related]
8. Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).
van Agthoven T; Looijenga LHJ
Oncotarget; 2017 Aug; 8(35):58037-58049. PubMed ID: 28938535
[TBL] [Abstract][Full Text] [Related]
9. Micro-RNA-371a-3p in Germ Cell Testicular Tumors on Diagnosis: A Prospective Case-Control Study in Turkish Population.
Kılınç MT; Göger YE; Özkent MS; Kılıç Ö; Okur Altındaş B; Yıldırım MS; Karalezli G
Urol J; 2024 Apr; ():. PubMed ID: 38629199
[TBL] [Abstract][Full Text] [Related]
10. Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events.
Li X; Chen J; Hu X; Huang Y; Li Z; Zhou L; Tian Z; Ma H; Wu Z; Chen M; Han Z; Peng Z; Zhao X; Liang C; Wang Y; Sun L; Chen J; Zhao J; Jiang B; Yang H; Gui Y; Cai Z; Zhang X
PLoS One; 2011; 6(7):e22570. PubMed ID: 21799901
[TBL] [Abstract][Full Text] [Related]
11. Current outstanding challenges in germ cell tumors.
Salous T; Adra N
Curr Opin Oncol; 2024 May; 36(3):169-173. PubMed ID: 38573206
[TBL] [Abstract][Full Text] [Related]
12. Advancing GCT Management: A Review of miR-371a-3p and Other miRNAs in Comparison to Traditional Serum Tumor Markers.
Seales CL; Puri D; Yodkhunnatham N; Pandit K; Yuen K; Murray S; Smitham J; Lafin JT; Bagrodia A
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611057
[TBL] [Abstract][Full Text] [Related]
13. Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells.
Giuliano CJ; Freemantle SJ; Spinella MJ
Curr Cancer Ther Rev; 2006 Aug; 2(3):255-270. PubMed ID: 24482633
[TBL] [Abstract][Full Text] [Related]
14. Recent Advancements in Research on DNA Methylation and Testicular Germ Cell Tumors: Unveiling the Intricate Relationship.
Nicu AT; Ionel IP; Stoica I; Burlibasa L; Jinga V
Biomedicines; 2024 May; 12(5):. PubMed ID: 38791003
[TBL] [Abstract][Full Text] [Related]
15. Improving outcomes in germ cell cancers using miRNA.
Conduit C; Tran B
Ther Adv Med Oncol; 2021; 13():17588359211027826. PubMed ID: 34262617
[TBL] [Abstract][Full Text] [Related]
16. Re: Detection of Recurrence Through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.
Fankhauser CD; Cathomas R; Gillessen S; Rothermundt C
Eur Urol; 2024 May; ():. PubMed ID: 38735820
[No Abstract] [Full Text] [Related]
17. An update on the genetic predisposition of testicular germ cell tumors.
Islam R; Hansen A; Liesen A; Schorle H
Transl Androl Urol; 2024 Mar; 13(3):476-478. PubMed ID: 38590959
[No Abstract] [Full Text] [Related]
18. Referring to the article published on pp. 400-406 of this issue: Progress and challenges in testicular cancer microRNAs.
Konneh BK; Lafin JT; Bagrodia A
Asian J Urol; 2021 Oct; 8(4):341-342. PubMed ID: 34765441
[No Abstract] [Full Text] [Related]
19. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
